Trials / Recruiting
RecruitingNCT04088422
Cell Free DNA in Mature B-cell Lymphoma
Prospective, Observational Study on Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Lymphoma Management
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | peripheral blood collection | peripheral blood collection at treatment start, interm PET/CT, end of treatment PET/CT, one-year and two-year follow-up and or progression or relapse |
Timeline
- Start date
- 2022-09-28
- Primary completion
- 2024-12-01
- Completion
- 2026-12-01
- First posted
- 2019-09-12
- Last updated
- 2023-02-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04088422. Inclusion in this directory is not an endorsement.